US FDA Likely to Conclude Full Approval of Pfizer COVID Vaccine Within the Year

[Asia Economy New York=Correspondent Baek Jong-min] The U.S. Food and Drug Administration (FDA) is expected to soon decide on the full approval of Pfizer's COVID-19 vaccine.

[Image source=Reuters Yonhap News]

On the 16th (local time), CNN reported that the FDA has announced its intention to prioritize the review of Pfizer's application for full vaccine approval.

Pfizer applied for full approval last May. According to the FDA's plan, approval within this year is highly likely. An FDA official stated, "There is a possibility that the decision on full approval will be made within two months."

Pfizer's vaccine received emergency use authorization from the FDA in December last year and vaccinations began. Moderna, which also developed a vaccine using messenger RNA (mRNA) technology like Pfizer, applied for full approval from the FDA in June.

This content was produced with the assistance of AI translation services.